- Home
- SLS vs WNEB Comparison
SLS vs WNEB Comparison
Compare SLS & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | WNEB |
|---|---|---|
| Founded | 2012 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 246.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | WNEB |
|---|---|---|
| Price | $1.54 | $12.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 3.4M | 38.6K |
| Earning Date | 11-12-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | N/A | ★ 27.15 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $79,080,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.48 |
| P/E Ratio | ★ N/A | $18.74 |
| Revenue Growth | N/A | ★ 9.08 |
| 52 Week Low | $0.77 | $7.63 |
| 52 Week High | $2.48 | $12.82 |
Technical Indicators
Market Signals| Indicator | SLS | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 72.71 |
| Support Level | $1.39 | $12.10 |
| Resistance Level | $1.64 | $12.35 |
| Average True Range (ATR) | 0.12 | 0.37 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 57.69 | 98.68 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.